Spiraldot Health provides AI-powered clinical decision support specifically for oncology care. This platform addresses provider shortages and knowledge variability by offering comprehensive, unified support for multidisciplinary treatment planning. The system aims to improve cancer survival rates, reduce recurrence, and lower overall healthcare costs for patients.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cancer treatment often suffers from fragmented care due to disparate systems, provider shortages, and a lack of standardized clinical decision support, leading to variability in patient outcomes. Multidisciplinary meetings, which can improve survival rates, are not consistently implemented, and providers operate with varying levels of knowledge.
Solution
Spiraldot Health offers an AI-powered clinical decision support (CDS) platform designed to integrate with electronic health records (EHRs) and address inconsistencies in cancer care. The platform analyzes oncology data to facilitate multidisciplinary collaboration, enhance treatment decisions, and improve patient outcomes. By providing comprehensive clinical decision support, Spiraldot Health aims to reduce healthcare costs and ensure consistently excellent cancer care regardless of circumstance or location. The AI-driven insights help standardize treatment approaches and bridge knowledge gaps among providers.
Target Audience
The primary target audience includes oncologists, hospitals, and healthcare systems seeking to improve cancer treatment outcomes through AI-enhanced clinical decision support and multidisciplinary collaboration.
Features
- AI-driven analysis of oncology data integrated directly within existing EHR systems
- Facilitates multidisciplinary team collaboration through a unified platform
- Provides clinical decision support to standardize and enhance cancer treatment plans
- Aims to improve patient survival rates, reduce cancer recurrence, and enhance quality of life
- Designed to reduce healthcare costs associated with cancer treatment
- Compliant with SOC 2, HIPAA, FHIR, and Drata standards